- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.11. | OnKure Therapeutics announces accounting firm change | 5 | Investing.com | ||
| 07.11. | OnKure Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| ONKURE THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 07.11. | OnKure Therapeutics, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 01.11. | OnKure Therapeutics, Inc.: OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium | 2 | GlobeNewswire (USA) | ||
| 25.10. | vTv Therapeutics ends key license agreement with OnKure | 2 | Investing.com | ||
| 23.10. | OnKure files to sell 2.94M shares of Class A Common Stock for holders | 4 | Seeking Alpha | ||
| 10.10. | Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm | 1 | Benzinga.com | ||
| 10.10. | OnKure started at outperform by Oppenheimer, OKI-219 potential cited | 2 | Seeking Alpha | ||
| 10.10. | OnKure shares initiated with Outperform rating on drug potential | 2 | Investing.com | ||
| 08.10. | OnKure Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.10. | OnKure and Reneo Pharmaceuticals complete merger | 2 | Pharmaceutical Technology | ||
| 04.10. | OnKure Therapeutics, Inc. Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million | 155 | GlobeNewswire (Europe) | -- OnKure is focused on advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Ka), initially in breast cancer -- On track to announce early clinical... ► Artikel lesen | |
| 03.10. | Reneo Pharmaceuticals stockholders approve merger with OnKure | 1 | Seeking Alpha | ||
| 03.10. | Reneo Pharmaceuticals, Inc.: Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure | 133 | GlobeNewswire (Europe) | - Combined company to trade on Nasdaq under ticker "OKUR" - Reneo announces 1-for-10 reverse split of common stock IRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq:... ► Artikel lesen | |
| 03.10. | Reneo Pharmaceuticals secures stockholder approval for OnKure merger | 4 | Investing.com | ||
| 02.10. | Reneo Pharmaceuticals, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 19.09. | Reneo Pharmaceuticals executive buys over $76k in company stock | 2 | Investing.com | ||
| 17.09. | Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying | 2 | Benzinga.com | ||
| 13.09. | Reneo Pharmaceuticals kündigt Ausscheiden einer Führungskraft im Zuge der Fusion an | 2 | Investing.com Deutsch | ||
| 13.09. | Reneo Pharmaceuticals, Inc. - 8-K, Current Report | 1 | SEC Filings |
Seite:
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PFIZER | 23,595 | -0,32 % | Pfizer, BioNTech & Co: Trump-Ankündigung setzt Aktien unter Druck | Die Aktien von Impfstoff-Unternehmen stehen zum Wochenschluss deutlich unter Druck. Sowohl Moderna, als auch BioNTech, Pfizer und Novavax notieren im vorbörslichen US-Handel im Minus. Auch andere Pharmawerte... ► Artikel lesen | |
| INNOCAN PHARMA | 0,146 | +4,68 % | Innocan Pharma meldet Finanzergebnisse für das dritte Quartal 2024 | 2,7-facher Umsatzzuwachs im Jahresvergleich auf 24 Mio. US$ im Zeitraum von 9 Monaten
Herzliya, Israel und Calgary, Alberta - 20. November 2024 / IRW-Press / Innocan Pharma Corporation... ► Artikel lesen | |
| ASTRIA THERAPEUTICS | 9,050 | -0,55 % | Astria TherapeuticS GAAP EPS of -$0.42 in-line | ||
| ASSEMBLY BIOSCIENCES | 14,200 | -0,35 % | Assembly Biosciences - Herpes-Wirkstoff übertrifft Erwartungen | Mein diesjähriger Top-Favorit Assembly Biosciences (WKN: A402CB) präsentierte gestern herausragende Studiendaten seines Wirkstoffkandidaten ABI-5366 zur Behandlung von wiederkehrendem Genitalherpes.... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 0,933 | -2,25 % | Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence | - NKTR-422 demonstrated inflammation resolution and tissue repair in multiple preclinical models of chronic inflammatory conditions -
SAN FRANCISCO, Nov. 18,... ► Artikel lesen | |
| ALTIMMUNE | 7,538 | -1,26 % | Altimmune, Inc: Altimmune Presents New Data on the Effect of Pemvidutide on Inflammatory Lipids in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) at The Liver Meeting 2024 | ||
| ROCKET LAB USA | 19,020 | -0,63 % | Is Rocket Lab Stock a Millionaire Maker? | ||
| TALPHERA | 0,633 | -5,38 % | Talphera, Inc.: Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update | Five sites actively screening with multiple patients having completed the study; two additional institutions expected to begin screening in the fourth quarter totaling... ► Artikel lesen | |
| SOLIGENIX | 3,510 | 0,00 % | Soligenix, Inc.: Soligenix to Present at November 21st Virtual Investor Summit Microcap Event | PRINCETON, NJ / ACCESSWIRE / November 15, 2024 / Soligenix, Inc. (Nasdaq:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to... ► Artikel lesen | |
| KALA BIO | 6,200 | -0,40 % | KALA BIO, Inc. - 10-Q, Quarterly Report | ||
| BOIRON | 29,700 | +1,37 % | BOIRON: EVOLUTION OF GOVERNANCE | July 3rd, 2024
The Board of Directors of Laboratoires BOIRON, meeting today under the chairmanship of Thierry BOIRON, has enacted an evolution of the Group's governance.
In this context, Thierry... ► Artikel lesen | |
| NEUROGENE | 14,300 | -9,49 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 20.11.2024 | The following instruments on XETRA do have their first trading 20.11.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 20.11.2024
Aktien
1 PLRNBWT00031 Rainbow Tours S.A.
2... ► Artikel lesen | |
| HARROW | 42,440 | 0,00 % | Pre-market Movers: California BanCorp, Harrow, Inc., Quantum Computing, BTC Digital, Calidi Biotherapeutics | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.15 A.M. ET).In the Green California BanCorp. (BCAL) is up over 33% at $23.01.
Quantum... ► Artikel lesen | |
| MEDICINOVA | 1,700 | 0,00 % | MediciNova, Inc.: MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders | LA JOLLA, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| ESSA PHARMA | 1,745 | 0,00 % | ESSA Pharma: NBC-Anlegerclub feiert schnelle +23% Rendite! | Der No Brainer Club (NBC) hat erneut sein Gespür für unterbewertete Biotech-Perlen unter Beweis gestellt. Mit ESSA Pharma konnten Mitglieder in diesem fulminanten Biotech-Herbst innerhalb weniger Tage... ► Artikel lesen |
ONKURE THERAPEUTICS INC gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 16,060 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ONKURE THERAPEUTICS INC finden Sie auf Wallstreet Online.
